- Research article
- Open Access
Safety of esophagogastroduodenoscopy-guided forceps biopsy and the feasibility of esophagogastroduodenoscopy for evaluation of hypopharyngeal cancer
BMC Surgery volume 19, Article number: 105 (2019)
There is currently no established standard tissue sampling method for hypopharyngeal cancer. The present study aimed to evaluate the feasibility of esophagogastroduodenoscopy (EGD) for the pretreatment evaluation of hypopharyngeal cancer and the safety of EGD-guided forceps biopsy.
We reviewed nine patients with hypopharyngeal cancer who underwent EGD for the evaluation of tumor extent and tissue biopsy from March 2014 to March 2017 at International St. Mary’s Hospital. One experienced endoscopist performed all the EGD procedures in the presence of a head and neck surgeon. The procedure included determining tumor location, extent (presence of pyriform sinus apex involvement), and size, and passing the endoscope through the upper esophageal sphincter. The success rate of tissue sampling was assessed, and procedure-related complications were recorded.
All patients were male, with a mean age of 69.9 ± 10.9 years (range 61–69 years). Tissue sampling using biopsy forceps was performed in 6/9 patients (66.7%). No complications related to moderate sedation or biopsy, including post-biopsy bleeding or respiratory distress, were reported. Histologic confirmation was successful in 5/6 patients (83.3%). Upper gastrointestinal lesions were evaluated in 7/9 (77.8%) patients in whom the scope passed through the lesion.
EGD and EGD-guided forceps biopsy may be useful for the evaluation of hypopharyngeal cancer extent and tissue sampling, respectively.
Hypopharyngeal cancer accounts for approximately 5% of all head and neck cancers [1, 2]. Anatomically, the hypopharynx extends from the plane of the hyoid bone above to the plane of the inferior border of the cricoid cartilage below. Hypopharyngeal cancer usually does not cause symptoms until late in the disease course  and has a higher incidence of early metastasis and poorer prognosis than laryngeal cancer .
Hypopharyngeal cancer is relatively uncommon and anatomically complex. Various treatment options have been used based on its stage . The results of radiotherapy alone are comparable to those of partial surgery for early hypopharyngeal cancer . Surgical resection, followed by radiotherapy, if necessary, reportedly results in a better survival rate in patients with advanced cancers [7, 8]. However, the potential consequences of a radical surgical approach include significant alterations in voice and swallowing function, or complete loss of one or both. Complications such as fistulas and stenosis are common, and patients may require further surgery if they survive . Therefore, it is important to select the best treatment option.
Pretreatment diagnosis includes histologic confirmation and staging. Although squamous cell carcinoma comprises more than 90% of cancers of the hypopharynx , histological confirmation of the tumor is essential. Direct visualization of the lesion using a rigid laryngoscope under general anesthesia and tissue sampling is currently the standard diagnostic method. Patients with hypopharyngeal cancer are usually of old age and present with medical comorbidities. Therefore, a surgical procedure under general anesthesia is a burden for both the patient and the surgeon.
Upper gastrointestinal endoscopes have some advantages over rigid or flexible laryngoscopes, as they have better resolution and flexibility and can detect concomitant esophageal squamous dysplasia or carcinoma. Wang et al.  described the evaluation of upper gastrointestinal non-neoplastic lesions using an ultrathin endoscope. Due to the risk of bleeding and airway obstruction, however, tissue sampling using a gastroscope is not the procedure of choice. As of yet, no standard diagnostic test has been established. The present study aimed to evaluate the feasibility of gastroscopy for the evaluation of tumor extent, and the safety of tissue sampling using a gastroscope.
The medical records of consecutive primary hypopharyngeal cancer patients who underwent esophagogastroduodenoscopy (EGD) from March 2014 to March 2017 at International St. Mary’s Hospital were retrospectively reviewed. Hypopharyngeal tumors were detected via neck computed tomography (CT), magnetic resonance imaging (MRI), and/or laryngoscopy before EGD. All study protocols were retrospectively approved by our institutional review board (submission number IS17RASI0065).
EGD and tissue sampling
One endoscopist (Kim YJ) performed all EGD procedures in the presence of one head and neck surgeon (Hong HJ). A single-channel gastroscope (GIF-Q260J, Olympus, Tokyo, Japan) or an ultrathin endoscope (GIF-XP260N, Olympus, Tokyo, Japan) was used with or without sedation. Tissue sampling was performed using disposable biopsy forceps (FB-230 K, Olympus, Tokyo, Japan). Inspection, photography, and narrow-band imaging of hypopharyngeal lesions were performed both before and after passage through the pyriform sinus. During EGD, primary tumor extent, scope passage through the pyriform sinus, number of tissue samples taken using biopsy forceps, and the presence or absence of concomitant esophageal and gastric lesions were recorded. After EGD, we also assessed the accuracy of diagnosis based on EGD-guided biopsy histology and post-procedure complications, including post-biopsy hemorrhage or perforation. The accuracy of pathologic diagnosis using EGD guided forceps biopsy and passage of the endoscope through the tumor were evaluated.
Table 1 shows the demographic data and clinical staging of the nine patients. All patients were male, with a mean age of 69.9 ± 10.9 years (range 61–69 years). Five patients underwent concurrent chemoradiation therapy, and the other four were administered best palliative care.
Tumors were located in the pyriform sinus, post-cricoid area, and posterior pharyngeal wall (Fig. 1). The lesions were located in the pyriform sinus in 5/9 patients (Table 2). Endoscopy was observed in real time by one ear, nose, and throat specialist (Hong HJ) (Additional file 1: Video S1), who assessed tumor location and extent, as well as the involvement of the pyriform sinus inlet.
EGD was performed with sedation in six patients and without sedation in three. The sedatives used were midazolam (0.07–0.15 mg/kg, intravenous) and pethidine (25–50 mg, intravenous). In two patients, the endoscope could not pass through the hypopharyngeal mass. In one patient, only an ultrathin endoscope could pass through the mass. Biopsy using forceps was performed in 6/9 patients (66.7%) (Fig. 2). In 3/9 patients, the role of EGD was confined to the evaluation of tumor extent. The success rate of forceps biopsy was 83.3% (5/6 patients). The number of tissue fragments ranged from two to four. The success of forceps biopsy was not significantly associated with the number of tissue fragments, location of the lesion, or use of sedation.
Procedures were performed on hospitalized patients. No complications related to moderate sedation or biopsy, including respiratory distress or post-biopsy bleeding, were reported. Concomitant upper gastrointestinal lesions included esophageal candidiasis, intestinal metaplasia, peptic ulcer scar, and duodenal polyp. No synchronous cancers were detected.
In the United States and Canada, 65–85% of hypopharyngeal carcinomas involve the pyriform sinuses, 10–20% involve the posterior pharyngeal wall, and 5–15% involve the post-cricoid area . Due to its anatomical complexity, no standard treatment for cancer of the hypopharynx has been established. Expert guidelines recommend surgical resection for T1 cancer . Expert guidelines recommend biopsy of the primary site or fine-needle aspiration of the neck, chest CT, CT with contrast, and/or MRI with contrast of the primary site and neck, and endoscopy under anesthesia for pretreatment evaluation . To select surgical candidates, tumor extent should be evaluated. Rigid laryngoscopy under general anesthesia is usually the diagnostic method of choice.
Developments in endoscopy have made minimally invasive treatment possible in diseases of various organs. Flexible endoscopy has advantages over rigid laryngoscopy in that it is less uncomfortable for patients and does not require sedation. Gastrointestinal endoscopy yields better resolution than flexible laryngoscopy, and enables the concomitant evaluation of esophageal, gastric, and duodenal lesions.
Five studies have reported that office-based biopsy for head and neck cancers under local anesthesia using flexible digital video laryngoscopy or transnasal fiberoptic endoscopy is safe and can successfully yield a histopathological diagnosis [13,14,15,16,17]. Of these five studies, three included hypopharyngeal cancer patients (n = 2 a, n = 8 d n = 8), while the other two included only laryngeal cancer patients. Hypopharyngeal cancer extends below the pyriform sinus inlet, and sometimes lesions are not visible via laryngoscopy. Moreover, the incidence of synchronous esophageal dysplasia or carcinoma is higher in patients with hypopharyngeal cancer than in the general population, and upper gastrointestinal endoscopy is essential. Biopsy and upper gastrointestinal evaluation can be achieved using upper gastrointestinal endoscopes.
The success rate of tissue biopsy was 83.3% in the current study. In a previous study of hypopharyngeal cancer, the success rate was 100% . The reported success rates of forceps biopsy through an endoscope biopsy channel in this and previous studies are acceptable; however, the currently available reported sample sizes are small.
No complications, including post-biopsy bleeding or respiratory distress during endoscopy, were observed in the present study. Mild to moderate sedation is needed, however, due to retching.
The study had some limitations. First, it was a single-center retrospective study, which may limit the reach of the conclusions; second, the study had a small sample size.
EGD appears to be a feasible option for the pretreatment diagnosis and biopsy of hypopharyngeal cancer; our limited sample size showed that an acceptable success rate may be achieved. EGD can reduce the burden of general anesthesia and enables the concomitant evaluation of upper gastrointestinal lesions.
Availability of data and materials
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
Magnetic resonance imaging
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
Hypopharyngeal Cancer Treatment (PDQ(R)): Health professional version. In: PDQ Cancer Information Summaries. edn. Bethesda 2002. https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/books/NBK82221/.
Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK, Gay EG, Langer CJ. National Cancer Database report on cancer of the head and neck: 10-year update. Head & neck. 2009;31(6):748–58.
Bradley PJ. Cancer of the hypopharynx. Oper Tech Otolaryngol Head Neck Surg. 2005;16(1):55–66.
Jones A. The management of early hypopharyngeal cancer: primary radiotherapy and salvage surgery. Clin Otolaryngol Allied Sci. 1992;17(6):545–9.
Kim S, Wu HG, Heo DS, Kim KH, Sung MW, Park CI. Advanced hypopharyngeal carcinoma treatment results according to treatment modalities. Head Neck. 2001;23(9):713–7.
Cheng CT, Lin CY, Hung-Chun Cheng S, Lin YP, Lim LC, Pennarun N, Liu ZY, Terng SD. Survival benefit of surgical approach for advanced oropharyngeal and hypopharyngeal cancer: a retrospective analysis. Head Neck. 2017;39(10):2104–13.
Sanderson RJ, Ironside JA. Squamous cell carcinomas of the head and neck. BMJ. 2002;325(7368):822–7.
Su YY, Chen WC Fau-Chuang H-C, Chuang HC, Fau-Guo C-S, Guo CS Fau-Lin Y-T, Lin YT Fau-Luo S-D, Luo SD Fau-Fang F-M, Fang FM Fau-Chien C-Y, Chien CY. Effect of routine esophageal screening in patients with head and neck cancer. JAMA Otolaryngology-Head and Neck Surgery. 2013;139(4):350–54.
Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet (London, England). 2000;355(9208):949–55.
Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ. NCCN guidelines insights: head and neck cancers, version 2.2017. J Natl Compr Cancer Netw. 2017;15(6):761–70.
Schutte HW, Takes RP, Slootweg PJ, Arts MJPA, Honings J, van den Hoogen FJA, Marres HAM, van den Broek GB. Digital video laryngoscopy and flexible endoscopic biopsies as an alternative diagnostic workup in laryngopharyngeal Cancer: a prospective clinical study. Ann Otol Rhinol Laryngol. 2018;127(11):770–6.
Cohen J, Benyamini L. Transnasal flexible Fiberoptic in-office laryngeal biopsies-our experience with 117 patients with suspicious lesions. Rambam Maimonides Med J. 2014;5(2):e0011.
Naidu H, Noordzij JP, Samim A, Jalisi S, Grillone G. Comparison of efficacy, safety, and cost-effectiveness of in-office cup forcep biopsies versus operating room biopsies for laryngopharyngeal tumors. J Voice. 2012;26(5):604–6.
Cha W, Yoon B-W, Jang J, Lee J, Lee B, Wang S-G, Cho J, Cho I. Office-based biopsies for laryngeal lesions: analysis of consecutive 581 cases. Laryngoscope. 2016;126(11):2513–9.
Lippert D, Hoffman M, Dang P, McCulloch T, Hartig G, Dailey S. In-office biopsy of upper airway lesions: safety, tolerance, andEffect on time to treatment. Laryngoscope. 2015;125(4):919–23.
Narration of the video clip was recorded by Na Yong Kim.
This study was presented at Asia-Pacific Digestive Week (APDW) 2018 (OE-0856 (PE-0188)).
This study was not funded by an external source.
Ethics approval and consent to participate
This study was approved by the Institutional Review Board (IRB) of the International Saint Mary’s Hospital (submission number IS17RASI0065). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent forms about the procedure were obtained for all patients before surgery.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hong, H.J., Jeong, S., Kim, W.S. et al. Safety of esophagogastroduodenoscopy-guided forceps biopsy and the feasibility of esophagogastroduodenoscopy for evaluation of hypopharyngeal cancer. BMC Surg 19, 105 (2019). https://0-doi-org.brum.beds.ac.uk/10.1186/s12893-019-0571-z
- Forceps biopsy
- Hypopharyngeal cancer